U.S. markets closed

Clearside Biomedical, Inc. (CLSD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.7200+0.1000 (+3.82%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/7/2021
Current
12/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
150.86M142.10M74.27M87.00M76.28M
Enterprise Value 3
135.55M129.31M61.32M72.44M60.09M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
15.4412.5110.0712.3329.86
Price/Book (mrq)
17.2217.4910.198.336.84
Enterprise Value/Revenue 3
17.1711.76k17.87204.6514.67
Enterprise Value/EBITDA 7
-7.63-18.30-25.70-13.14-21.53

Trading Information

Stock Price History

Beta (5Y Monthly) 1.38
52-Week Change 332.32%
S&P500 52-Week Change 343.39%
52 Week High 34.5300
52 Week Low 31.2500
50-Day Moving Average 32.6882
200-Day Moving Average 32.6629

Share Statistics

Avg Vol (3 month) 3356.1k
Avg Vol (10 day) 3163.26k
Shares Outstanding 557.58M
Implied Shares Outstanding 6N/A
Float 44.34M
% Held by Insiders 113.00%
% Held by Institutions 137.75%
Shares Short (Apr 14, 2021) 4965.23k
Short Ratio (Apr 14, 2021) 43.21
Short % of Float (Apr 14, 2021) 42.11%
Short % of Shares Outstanding (Apr 14, 2021) 41.68%
Shares Short (prior month Mar 14, 2021) 4656.57k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin -230.68%
Operating Margin (ttm)-227.20%

Management Effectiveness

Return on Assets (ttm)-48.63%
Return on Equity (ttm)-182.83%

Income Statement

Revenue (ttm)7.89M
Revenue Per Share (ttm)0.17
Quarterly Revenue Growth (yoy)-99.40%
Gross Profit (ttm)7.89M
EBITDA -17.75M
Net Income Avi to Common (ttm)-18.21M
Diluted EPS (ttm)-0.3920
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)17.29M
Total Cash Per Share (mrq)0.3
Total Debt (mrq)1.98M
Total Debt/Equity (mrq)22.59
Current Ratio (mrq)1.82
Book Value Per Share (mrq)0.17

Cash Flow Statement

Operating Cash Flow (ttm)-13.12M
Levered Free Cash Flow (ttm)-6.4M